Connection

DAVID POPLACK to Precursor Cell Lymphoblastic Leukemia-Lymphoma

This is a "connection" page, showing publications DAVID POPLACK has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
  1. Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15; 25(4):328-35.
    View in: PubMed
    Score: 0.224
  2. Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. Leukemia. 1994 Jun; 8(6):963-7.
    View in: PubMed
    Score: 0.069
  3. A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer Chemother Pharmacol. 1992; 30(2):155-7.
    View in: PubMed
    Score: 0.059
  4. Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patterns. Leukemia. 1991 Dec; 5(12):1015-25.
    View in: PubMed
    Score: 0.058
  5. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am J Pediatr Hematol Oncol. 1990; 12(2):174-81.
    View in: PubMed
    Score: 0.051
  6. Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? Am J Pediatr Hematol Oncol. 1989; 11(3):324-6.
    View in: PubMed
    Score: 0.048
  7. Late CNS sequelae in long term survivors of childhood leukemia. An Esp Pediatr. 1988 Oct; 29 Suppl 34:19-26.
    View in: PubMed
    Score: 0.047
  8. Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
    View in: PubMed
    Score: 0.041
  9. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
    View in: PubMed
    Score: 0.024
  10. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood. 1998 Nov 15; 92(10):3569-77.
    View in: PubMed
    Score: 0.024
  11. Detection of double minute chromosomes in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1998 Mar; 101(2):138-42.
    View in: PubMed
    Score: 0.023
  12. A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Clin Cancer Res. 1997 May; 3(5):713-7.
    View in: PubMed
    Score: 0.021
  13. Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice. Oncogene. 1995 Nov 02; 11(9):1753-9.
    View in: PubMed
    Score: 0.019
  14. Advances in the treatment of meningeal cancers. Crit Rev Oncol Hematol. 1995 Aug; 20(1-2):87-98.
    View in: PubMed
    Score: 0.019
  15. The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res. 1994 Nov; 18(11):805-10.
    View in: PubMed
    Score: 0.018
  16. Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
    View in: PubMed
    Score: 0.015
  17. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992 Feb; 89(2):640-7.
    View in: PubMed
    Score: 0.015
  18. Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh). 1991 Apr; 124(4):375-80.
    View in: PubMed
    Score: 0.014
  19. Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens. Arch Pathol Lab Med. 1991 Apr; 115(4):338-42.
    View in: PubMed
    Score: 0.014
  20. Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia. N Engl J Med. 1990 Nov 29; 323(22):1565-6.
    View in: PubMed
    Score: 0.014
  21. Pharmacology and drug resistance in childhood lymphoblastic leukemia. Hematol Oncol Clin North Am. 1990 Oct; 4(5):871-94.
    View in: PubMed
    Score: 0.013
  22. Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol. 1990 Mar; 8(3):431-42.
    View in: PubMed
    Score: 0.013
  23. Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood. 1989 Sep; 74(4):1388-95.
    View in: PubMed
    Score: 0.012
  24. Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol. 1988 Dec; 6(12):1882-6.
    View in: PubMed
    Score: 0.012
  25. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986; 3(4):319-24.
    View in: PubMed
    Score: 0.010
  26. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9.
    View in: PubMed
    Score: 0.009
  27. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.